-
Views
-
Cite
Cite
Daniela V. Frau, Maria L. Lai, Paola Caria, Tinuccia Dettori, Pierpaolo Coni, Gavino Faa, Luca Morandi, Giovanni Tallini, Roberta Vanni, Trisomy 17 as a Marker for a Subset of Noninvasive Thyroid Nodules with Focal Features of Papillary Carcinoma: Cytogenetic and Molecular Analysis of 62 Cases and Correlation with Histological Findings, The Journal of Clinical Endocrinology & Metabolism, Volume 93, Issue 1, 1 January 2008, Pages 177–181, https://doi.org/10.1210/jc.2007-0970
- Share Icon Share
Abstract
Context: Differentiated carcinomas of the thyroid are divided into follicular thyroid carcinoma and papillary thyroid carcinoma (PTC), based on their propensity to invade and their cytological features [papillary carcinoma-type nuclear changes (PTC-NCs)]. PTC typically exhibits a diploid karyotype sometimes with inv10(q11.2q21.2), leading to rearranged RET gene. Follicular thyroid carcinomas are often aneuploid and may exhibit t(2;3)(q13;p25), resulting in PAX8-PPARγ1 gene fusion. Isolated trisomy 17 has rarely been reported in thyroid lesions, and its significance is unknown.
Objective/Design: Our objective was to determine whether isolated trisomy 17 corresponds to a specific histological or molecular thyroid tumor subset. Nine cases with isolated trisomy 17 were critically reviewed and investigated for RAS and BRAF mutations and for RET and PAX8-PPARγ1 rearrangements.
Results: All nine cases were noninvasive, exhibited follicular growth pattern, and showed PTC-NCs focally defined within the nodule: four were PTCs follicular variant within larger tumors, and five were follicular-patterned nodules with incomplete cytological features of papillary carcinoma (variable proportion of cells with PTC-NCs scattered inside the lesion). RAS, BRAFV600E mutation, RET or PAX8-PPARγ1 rearrangements were not identified. One case had BRAFK601E mutation. Only two of the 53 control cases showed focal PTC-NCs.
Conclusions: Isolated trisomy 17 is associated with focal papillary carcinoma changes in follicular-patterned thyroid nodules and may be a marker for this subset of thyroid lesions that are often difficult to classify.